A Phase II Clinical Trial Evaluating Ipilimumab & Nivolumab in Combination for the Treatment of Rare Gastrointestinal, Neuro-Endocrine and Gynaecological Cancers

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/16/Austin/152
NMA SSA Reference Number: SSA/17/MonH/453
Monash Health Reference Number: RES-17-0000-515X
Effective start/end date11/01/1910/01/24


  • clinical trial
  • treatment efficacy
  • Gynaecological Cancer
  • Gastrointestinal cancer
  • Neuro-Endocrine cancer